Custom Search Insider Trading Activity Insider Trading Activity
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Custom Search Insider Trading Activity
Updated Feb 20, 2024
Ticker
|
Company Name
|
Qty.
|
Price
|
Size ($)
|
Filing Date
|
Type
|
Δ Own
|
Own
|
Insider Names
|
Title
|
Trade Dates
|
Is Scheduled
| |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Spyre Therapeutics, Inc.
| 400 |
$9.82 | $3,928.00 | +0.05% | 746.91K |
Feb 15
| |||||||
Spyre Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Feb 1
| |||||||
Spyre Therapeutics, Inc.
| 723.44K |
—
|
—
| +3,136.26% | 746.51K |
Nov 22 - Nov 24
| |||||||
Aeglea Biotherapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Eidos Therapeutics, Inc.
| -50.70K |
—
|
—
| -100.00% |
0
|
Jan 26
| |||||||
Bridgebio Pharma, Inc.
|
0
|
$38.14 | -$1,226,684.04 |
—
| 12.57K |
Dec 28
|
Scheduled
| ||||||
Eidos Therapeutics, Inc.
|
0
|
$62.81 | -$2,574,801.07 |
—
| 50.62K |
Dec 15
| |||||||
Bridgebio Pharma, Inc.
|
0
|
$32.02 | -$150,180.84 |
—
| 12.57K |
Nov 24 - Nov 25
|
Scheduled
| ||||||
Eidos Therapeutics, Inc.
| -14.91K |
$74.51 | -$999,227.30 | -22.75% | 50.62K |
Nov 11
| |||||||
Bridgebio Pharma, Inc.
|
0
|
$29.53 | -$62,624.75 |
—
| 12.57K |
Nov 5
|
Scheduled
| ||||||
Eidos Therapeutics, Inc.
| -5.00K |
$42.60 | -$775,453.57 | -7.09% | 65.53K |
Nov 2
|
Scheduled
| ||||||
Bridgebio Pharma, Inc.
|
0
|
$20.42 | -$500,957.74 |
—
| 12.57K |
Sep 30
|
Scheduled
| ||||||
Bridgebio Pharma, Inc.
|
0
|
$29.51 | -$62,524.25 |
—
| 12.57K |
Sep 18
|
Scheduled
| ||||||
Bridgebio Pharma, Inc.
|
0
|
$27.03 | -$50,151.75 |
—
| 12.57K |
Sep 15
|
Scheduled
| ||||||
Bridgebio Pharma, Inc.
|
0
|
$17.68 | -$69,367.00 |
—
| 12.57K |
Sep 11
|
Scheduled
| ||||||
Eidos Therapeutics, Inc.
|
0
|
$32.00 | -$75,000.00 |
—
| 70.53K |
Sep 10
|
Scheduled
| ||||||
Bridgebio Pharma, Inc.
| 2.75K |
—
|
—
| +27.94% | 12.57K |
Sep 1
| |||||||
Eidos Therapeutics, Inc.
| -5.00K |
$26.57 | -$333,449.88 | -6.62% | 70.53K |
Aug 3
|
Scheduled
| ||||||
Bridgebio Pharma, Inc.
|
0
|
$16.44 | -$324,303.04 |
—
| 9.82K |
Jun 30
| |||||||
Eidos Therapeutics, Inc.
| 376 |
$41.57 | $15,631.64 | +0.50% | 75.53K |
May 31
| |||||||
Eidos Therapeutics, Inc.
|
0
|
$32.00 | -$75,000.00 |
—
| 75.16K |
May 26
|
Scheduled
| ||||||
Bridgebio Pharma, Inc.
|
0
|
—
|
—
|
—
|
0
|
May 19
| |||||||
Eidos Therapeutics, Inc.
| -5.00K |
$27.02 | -$342,433.21 | -6.24% | 75.16K |
May 1
|
Scheduled
| ||||||
Bridgebio Pharma, Inc.
|
0
|
$24.51 | -$30,027.60 |
—
| 9.82K |
Apr 27
|
Scheduled
| ||||||
Bridgebio Pharma, Inc.
|
0
|
$22.02 | -$80,357.60 |
—
| 9.82K |
Apr 8
|
Scheduled
| ||||||
Bridgebio Pharma, Inc.
|
0
|
$27.14 | -$40,564.20 |
—
| 9.82K |
Feb 11
|
Scheduled
| ||||||
Eidos Therapeutics, Inc.
| -5.00K |
$34.06 | -$562,139.79 | -5.87% | 80.16K |
Feb 3
|
Scheduled
| ||||||
Bridgebio Pharma, Inc.
| -2.81K |
$25.69 | -$270,210.99 | -22.22% | 9.82K |
Jan 8
|
Scheduled
| ||||||
Eidos Therapeutics, Inc.
|
0
|
$36.23 | -$460,451.63 |
—
| 85.16K |
Dec 6
| |||||||
Eidos Therapeutics, Inc.
| -10.00K |
$55.75 | -$557,501.77 | -10.51% | 85.16K |
Nov 20
| |||||||
Eidos Therapeutics, Inc.
| -5.00K |
$41.58 | -$207,922.94 | -4.99% | 95.16K |
Sep 4
| |||||||
Bridgebio Pharma, Inc.
| 12.63K |
—
|
—
|
∞
| 12.63K |
Jul 1
| |||||||
Bridgebio Pharma, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Eidos Therapeutics, Inc.
| -7.15K |
$21.83 | -$282,173.50 | -6.66% | 100.16K |
Nov 30 - Jun 4
| |||||||
Eidos Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
It looks like there's no data for these filter options. Maybe you'll be interested in these options instead. | |||||||||||||
Want to view more results?
Unlock the hidden results with your Benzinga Account now. No purchase required.